Cannabis Report
Lithium
Home > Boards > US OTC > Medical - Equipment > Arrayit Corporation (ARYC)

Blood cards paid by Medicare and Medicaid!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
techmover Member Profile
Member Level 
Followed By 87
Posts 11,855
Boards Moderated 2
Alias Born 04/13/10
160x600 placeholder
techmover Member Level  Thursday, 05/17/18 10:52:53 AM
Re: None
Post # of 94352 
Blood cards paid by Medicare and Medicaid!

“What this means is Arrayit’s blood cards have been given certification by CMS centers for Medicaid and Medicare services and their clinical laboratory amendments program including a license. This all means Arrayit blood cards will be used in any hospital, lab or clinic that partners with Medicaid and Medicare due to the effectiveness, low cost and certification by CMS of the blood cards.”

Further, Arrayit Corporation Scores 100% on Proficiency Testing Conducted by the College of American Pathologists as clinical team aces CAP PT in highly quantitative measurements of IgE using a blinded study protocol.

About the College of American Pathologists

As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.

Here are the two recent press releases.

Sunnyvale, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces that the company scored 100% on clinical laboratory proficiency testing conducted by the College of American Pathologists (CAP). Arrayit received a perfect score in highly quantitative measurements of immunoglobulin E (IgE), the antibodies in the human bloodstream indicative of allergy and asthma. The CAP SA2018 Diagnostic Immunology Survey proficiency test included 1,677 clinical laboratories utilizing IgE testing equipment manufactured by major corporations in the life sciences, molecular diagnostics and pharmaceutical markets. CAP, the international proficiency testing leader, ensures and improves healthcare quality by fostering clinical excellence through the impartial and carefully-supervised proficiency testing process.

Arrayit uses its patented and proprietary microarray technology to accurately and rapidly test IgE levels in patient blood card specimens shipped to its Silicon Valley clinical laboratory by hospitals, health maintenance organizations (HMOs), clinical laboratories, insured patients in physician groups, and consumers through the assistance of a medical doctor. Arrayit leverages miniaturization, allergen and sample multiplexing, and a high degree of robotic and software automation to deliver test results quickly and non-invasively using finger stick blood sampling

https://globenewswire.com/news-release/2018/05/16/1507332/0/en/Arrayit-Corporation-Scores-100-on-Proficiency-Testing-Conducted-by-the-College-of-American-Pathologists.html

Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amendments (CLIA) Program. Arrayit's new CLIA license, issued in conjunction with the Department of Health and Human Services (HHS) and the California Department of Public Health (CDPH), provides certification for its Silicon Valley clinical laboratory.

Arrayit has developed patented and proprietary microarray technology, validated through the CLIA program, to measure immunoglobulin E (IgE) and immunoglobulin G (IgG) levels for the purposes of allergy and dietary wellness testing. Arrayit tests employ non-invasive finger stick blood sampling, blood cards and a highly miniaturized and automated microarray format to deliver results accurately and quickly. The company enters the $3.2 trillion US healthcare market by offering its tests to hospitals, health maintenance organizations (HMOs), clinical laboratories, physician groups with patients covered by private and government health insurance, and consumers through the assistance of a medical doctor.

https://www.nasdaq.com/press-release/arrayit-corporation-announces-new-clinical-licensure-from-the-centers-for-medicare-and-medicaid-20180509-00731




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist